Universitätsklinikum Essen

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study (2022) Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, et al. Journal article Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/ Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis (2022) Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhaeuser M, Stelljes M, Finke J, et al. Journal article 14th Conference of the German Endocrine-Brain-Immune-Network (GEBIN) (2022) Capellino S, Engler H, Rohleder N Journal article LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis (2022) Leyh C, Heucke N, Schotten C, Büchter M, Bechmann LP, Wichert M, Dechêne A, et al. Journal article AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 (2022) Banys-Paluchowski M, Thill M, Kuhn T, Ditsch N, Heil J, Woeckel A, Fallenberg E, et al. Journal article A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression (2022) Tzaridis T, Weller J, Bachurski D, Shakeri F, Schaub C, Hau P, Buness A, et al. Journal article Inertial Gait Sensors to Measure Mobility and Functioning in Hereditary Spastic Paraplegia A Cross-sectional Multicenter Clinical Study (2022) Regensburger M, Spatz I, Ollenschläger M, Martindale C, Lindeburg P, Kohl Z, Eskofier B, et al. Journal article Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation (2022) Kunadt D, Stasik S, Metzeler KH, Roellig C, Schliemann C, Greif PA, Spiekermann K, et al. Journal article A randomized phase II trial of ipilimumab and nivolumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNNIFORECAST) (2022) Ahrens M, Escudier B, Haanen J, Gross-Goupil M, Boleti E, Gravis G, Grimm MO, et al. Conference contribution Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? (2022) Derigs P, Bethge W, Holtick U, Von Tresckow B, Ayuk F, Penack O, Vucinic V, et al. Conference contribution